瑞士双侧先天性白内障队列的遗传学分析
该研究对瑞士单中心25个家系37例双侧先天性白内障患者进行全外显子测序,在20个家系(80%)中检出致病变异,包括BCOR、COL4A1、CRYBA2等基因的13个新变异,并发现CRYBB2基因的隐性变异及NHS基因剪接变异的功能证据。
要点
- 双侧先天性白内障患者应进行基因检测,本队列致病变异检出率达80%。
- 已知显性基因(如CRYBB2)也可能呈隐性遗传模式。
- 轻度全身特征的患者中综合征型白内障可能被低估。
核心结论
- 双侧先天性白内障的遗传检测至关重要,本队列在80%家系中检出致病变异。
- 已知显性遗传基因需考虑隐性遗传模式,如CRYBB2基因的隐性变异。
- 轻度全身特征患者中综合征型白内障可能诊断不足。
研究设计与样本
- 临床与分子遗传学队列研究,由苏黎世大学医院眼科与苏黎世大学医学分子遗传研究所合作完成。
- 纳入25个家系37例不同型双侧先天性白内障患者,所有参与家庭成员接受全面眼科检查。
- 对先证者行全外显子测序,过滤已知先天性白内障相关基因的变异,并用Sanger测序在家系成员中确认。
- 数据收集于2018年1月至2020年6月,分子遗传分析于2019年1月至2020年7月进行。
主要发现
- 37例患者中男性18例(49%)、女性19例(51%),平均年龄17.3岁(SD 15.9)。
- 20个家系(80%)检出致病变异,涉及BCOR、COL4A1、CRYBA2、CRYBB2、CRYGC、CRYGS、GJA3、MAF、NHS和WFS1基因的13个新变异。
- 20个家系中14个(70%)为孤立病例,6个(30%)为综合征病例。
- 一个近亲家系中2例同胞患核性及缝性白内障,检出CRYBB2基因隐性变异,与既往报道不同。
- NHS基因新剪接位点变异c.[719-2A>G]在小基因试验中显示影响剪接,支持其致病性。
临床怎么用
- 对双侧先天性白内障患者应开展基因检测,以明确遗传病因。
- 分析显性遗传基因时需考虑隐性遗传模式的可能性。
- 对轻度全身特征的患者应警惕综合征型白内障,避免漏诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Identification of geographic population-based differences in genotype and phenotype heterogeneity are important for targeted and patient-specific diagnosis and treatment, counseling, and screening strategies. OBJECTIVE: To report disease-causing variants and their detailed phenotype in patients with bilateral congenital cataract from a single center in Switzerland and thereby draw a genetic map and perform a genotype-phenotype comparison of this cohort. DESIGN, SETTING, AND PARTICIPANTS: This clinical and molecular-genetic cohort study took place through the collaboration of the Department of Ophthalmology at the University Hospital Zurich and the Institute of Medical Molecular Genetics, University of Zurich, Schlieren, Switzerland. Thirty-seven patients from 25 families with different types of bilateral congenital cataract were included. All participating family members received a comprehensive eye examination. Whole exome sequencing was performed in the index patients, followed by a filtering process to detect possible disease-associated variants in genes previously described in association with congenital cataract. Probable disease-causing variants were confirmed by Sanger sequencing in available family members. All data were collected from January 2018 to June 2020, and the molecular-genetic analyses were performed from January 2019 to July 2020. MAIN OUTCOMES AND MEASURES: Identification of the underlying genetic causes of bilateral congenital cataract, including novel disease-causing variants and phenotype correlation. RESULTS: Among the 37 patients (18 [49%] male and 19 [51%] female; mean [SD] age, 17.3 [15.9] years) from 25 families, pathogenic variants were detected in 20 families (80% detection rate), which included 13 novel variants in the following genes: BCOR, COL4A1, CRYBA2, CRYBB2, CRYGC, CRYGS, GJA3, MAF, NHS, and WFS1. Putative disease-causing variants were identified in 14 of 20 families (70%) as isolated cases and in 6 of 20 families (30%) with syndromic cases. A recessive variant in the CRYBB2 gene in a consanguineous family with 2 affected siblings showing a nuclear and sutural cataract was reported in contrast to previously published reports. In addition, the effect on splicing in a minigene assay of a novel splice site variant in the NHS gene (c.[719-2A>G]) supported the pathogenicity of this variant. CONCLUSIONS AND RELEVANCE: This study emphasizes the importance of genetic testing of congenital cataracts. Known dominant genes need to be considered for recessive inheritance patterns. Syndromic types of cataract may be underdiagnosed in patients with mild systemic features.
引用
- Rechsteiner D, Issler L, Koller S, et al. Genetic Analysis in a Swiss Cohort of Bilateral Congenital Cataract. JAMA Ophthalmol. 2021. PMID: 34014271. doi:10.1001/jamaophthalmol.2021.0385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。